PlumX Metrics
Embed PlumX Metrics

Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model

Liver International, ISSN: 1478-3231, Vol: 36, Issue: 12, Page: 1765-1773
2016
  • 20
    Citations
  • 0
    Usage
  • 26
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

Background & Aims: No published study to date has provided a careful analysis of the effects of a sustained viral response (SVR) on the outcomes of patients with compensated hepatitis C virus (HCV)-related cirrhosis in relation to the degree of portal hypertension. Therefore, we estimated the impact of achieving SVR on disease progression, hepatocellular carcinoma (HCC) development and mortality in a large cohort of HCV patients with cirrhosis with or without oesophageal varices (OVs) at the start of antiviral therapy. Methods: A total of 535 Caucasian patients were prospectively recruited to this study. All patients had a clinical or histological diagnosis of compensated HCV-related cirrhosis and underwent interferon-based therapy. Competing risks and a multistate model were analysed according to the presence or absence of OVs at baseline. Results: Compared to patients without SVR, a greater proportion of patients who achieved SVR showed no liver disease progression after 10 years (36.3% vs. 61.3% of patients without baseline OVs; 29.6% vs. 64.3% of patients with baseline OVs). Achievement of SVR was significantly associated with reduced occurrence rates of de-novo OVs, hepatic decompensation and HCC. Compared to patients without SVR, patients with SVR had lower likelihoods of liver-related death at 10 years (20.6% vs. 10.3% of patients without baseline OVs; 50.5% vs. 21.8% of patients with baseline OVs). Conclusions: In patients with compensated HCV-related cirrhosis with or without OVs at baseline, SVR is associated with reduced disease progression and liver-related mortality.

Bibliographic Details

Petta, Salvatore; Di Marco, Vito; Bruno, Savino; Enea, Marco; Calvaruso, Vincenza; Boccaccio, Vincenzo; Rossi, Sonia; Craxì, Antonio; Cammà, Calogero

Wiley

Medicine

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know